CIK 0001620463 · Non-accelerated filer<br>Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 453368487
- Phone
- (425) 620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 85 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-24 | Renninger Robert Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +34,358 | 34,358 | ||
| 2025-12-24 | Worthington Mark General Counsel and CCO | Grant or award · Stock Option (Right to Buy) | +34,358 | 34,358 | ||
| 2025-12-24 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +35,138 | 35,138 | ||
| 2025-12-24 | San Martin Javier CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +44,508 | 44,508 | ||
| 2025-12-24 | Litton Mark James President and CEO | Grant or award · Stock Option (Right to Buy) | +133,526 | 133,526 | ||
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award | +989,270 | $6.35 | $6.3M | 1,529,566 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award | +329,756 | $6.35 | $2.1M | 329,756 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Pre-Funded Warrant (right to buy) | +1,372,935 | $6.35 | $8.7M | 1,372,935 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Series A Warrant (right to buy) | +3,838,583 | $6.35 | $24.4M | 3,838,583 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Series B Warrant (right to buy) | +3,543,307 | $6.35 | $22.5M | 3,543,307 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Pre-Funded Warrant (right to buy) | +457,645 | $6.35 | $2.9M | 457,645 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Series A Warrant (right to buy) | +1,279,526 | $6.35 | $8.1M | 1,279,526 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Series B Warrant (right to buy) | +1,181,101 | $6.35 | $7.5M | 1,181,101 |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Pre-Funded Warrant (right to buy) | +5,502,402 | 5,502,402 | ||
| 2025-11-18 | Renninger Robert Chief Financial Officer | Grant or award | +1,000 | $2.31 | $2K | 11,918 |
| 2025-11-18 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award | +1,000 | $2.31 | $2K | 17,890 |
| 2025-07-01 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | −8,526 | $0.29 | $3K | 168,901 |
| 2025-07-01 | Litton Mark James President and CEO | Sale | −25,123 | $0.29 | $7K | 325,802 |
| 2025-07-01 | San Martin Javier CHIEF MEDICAL OFFICER | Sale | −10,842 | $0.29 | $3K | 71,665 |
| 2025-07-01 | Worthington Mark General Counsel and CCO | Sale | −8,526 | $0.29 | $3K | 111,875 |
Page 4 of 10 · 187 trades